CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 28, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	0.05	0.03	0.13	0.12	1.39	0.78
Cash & Short-Term Investments	0.05	0.03	0.13	0.12	1.39	0.78
Cash Growth	22.97%	-79.63%	10.37%	-91.52%	78.30%	-77.92%
Prepaid Expenses	0	0	0.09	0.08	0.2	0.15
Total Current Assets	0.05	0.03	0.22	0.2	1.59	0.93
Property, Plant & Equipment	-	-	0.27	0.44	0.64	0.86
Long-Term Investments	-	-	-	0.18	0.85	0.43
Total Assets	0.05	0.03	0.5	0.81	3.08	2.22
Accounts Payable	0.06	0.04	0.34	0.46	0.18	0.23
Accrued Expenses	-	0.93	0.61	-	-	-
Short-Term Debt	1.4	1.3	1.34	1.76	0.87	-
Other Current Liabilities	1.16	0.24	0.22	0.22	0.22	0.22
Total Current Liabilities	2.62	2.51	2.52	2.44	1.27	0.45
Other Long-Term Liabilities	-	-	-	0	-	-
Total Liabilities	2.62	2.51	2.52	2.44	1.27	0.45
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-In Capital	22.48	22.47	22.24	18.03	17.06	15.37
Retained Earnings	-25.06	-24.95	-24.26	-20.55	-16.83	-13.63
Comprehensive Income & Other	-	-	-	0.88	1.55	0.01
Shareholders' Equity	-2.57	-2.48	-2.02	-1.63	1.81	1.76
Total Liabilities & Equity	0.05	0.03	0.5	0.81	3.08	2.22
Total Debt	1.4	1.3	1.34	1.76	0.87	-
Net Cash (Debt)	-1.35	-1.27	-1.21	-1.64	0.51	0.78
Net Cash Growth	-	-	-	-	-33.83%	-77.92%
Net Cash Per Share	-0.04	-0.04	-0.14	-1.34	0.45	0.69
Filing Date Shares Outstanding	4.2	31.11	28.31	1.26	1.24	1.13
Total Common Shares Outstanding	33.86	31.11	22.61	1.26	1.24	1.13
Working Capital	-2.57	-2.48	-2.29	-2.25	0.32	0.48
Book Value Per Share	-0.08	-0.08	-0.09	-1.30	1.46	1.57
Tangible Book Value	-2.57	-2.48	-2.02	-1.63	1.81	1.76
Tangible Book Value Per Share	-0.08	-0.08	-0.09	-1.30	1.46	1.57

Updated Jan 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.